Celularity (CELUW) Other financing activities (2019 - 2025)

Celularity (CELUW) reported Other financing activities of $103000.0 for Q4 2025, down 60.38% quarter-over-quarter from $260000.0 in Q3 2023.

Celularity (CELUW) Other financing activities (2019 - 2025) Analysis & Trends

Celularity (CELUW) has 5 years of Other financing activities data on file, last reported at $103000.0 in Q4 2025.

  • Other financing activities for Q4 2025 came in at $103000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $103000.0 (changed N/A YoY), and the FY2025 annual result was $103000.0, changed N/A from the prior year.
  • Other financing activities declined to $103000.0 in Q4 2025 per CELUW's latest filing, from $260000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $4.8 million in Q1 2021 and troughed at -$150000.0 in Q4 2022.
  • A 4-year average of $1.4 million and a median of $629500.0 in 2021 frame the typical range for Other financing activities.
  • The sharpest annual moves came in 2022 and 2023: Other financing activities sank 110.5% in 2022, then grew 12.55% in 2023.
  • A 4-year view of Other financing activities shows it stood at $1.4 million in 2021, then sank by 110.5% to -$150000.0 in 2022, then jumped by 273.33% to $260000.0 in 2023, then plunged by 60.38% to $103000.0 in 2025.
  • Business Quant data shows CELUW's Other financing activities at $103000.0 in Q4 2025, $260000.0 in Q3 2023, and -$150000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Celularity - - -3.27 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 103,000.00
Dec 31, 2025 103,000.00
Sep 30, 2023 260,000.00
Sep 30, 2023 260,000.00
Dec 31, 2022 -150,000.00
Dec 31, 2022 -150,000.00
Sep 30, 2022 231,000.00
Sep 30, 2022 231,000.00
Dec 31, 2021 1.43 Mn
Dec 31, 2021 1.43 Mn
Sep 30, 2021 3.59 Mn
Sep 30, 2021 3.59 Mn
Jun 30, 2021 999,000.00
Jun 30, 2021 999,000.00
Mar 31, 2021 4.84 Mn
Mar 31, 2021 4.84 Mn
Jun 30, 2019 505,717.00
Jun 30, 2019 505,717.00
Mar 31, 2019 5,150.00
Mar 31, 2019 5,150.00